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Background: Cerebral venous sinus thrombosis (CVT) is a rare and potentially life-threatening condition in the
pediatric population. The clinical presentation is frequently nonspecific; thus diagnosis is often delayed or missed.
Case presentation: A previously healthy 8 month-old boy was diagnosed with meningococcal meningitis. At hospital
admission, an urgent non contrast-enhanced computed tomography (CT) of the head and neck was performed with
normal results. Ceftriaxone was promptly started and the clinical condition of the patient improved. However, on the 7th
day of hospitalization, the child suddenly manifested irritability and lethargy. An urgent contrast-enhanced CT of the
head and neck was immediately performed, revealing thrombosis of the superior sagittal, transverse and rectus sinuses.
A thrombophilic evaluation was performed, revealing hyperhomocysteinemia and methylenetetrahydrofolate reductase
(MTHFR) variants (C677T and A1298C).
Conclusions: The causes of CVT may be categorized into three main groups: hypercoagulable states, conditions causing
blood flow disturbances, and all causes of inflammation or infection. In this case report, we observed more than one risk
factor that predisposed the patient to CVT. Consequently, even if a causative factor is detected, a thrombophilic blood
evaluation should be performed. In fact, in case of a prothrombotic condition, the patient’s family should be advised that
prompt administration of anticoagulant is necessary in the event of situations that could lead to thrombosis. Finally, CVT
may be considered a possible complication of infection even when recent imaging results are normal. A prompt CVT
diagnosis is required to obtain a good outcome. Delayed diagnosis is mainly due to the rarity of the disease and
physicians’ unawareness of this type of complication.
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Cerebral venous sinus thrombosis (CVT) is a rare, po-
tentially life-threatening disorder that may have vital or
morbid consequences, such as motor dysfunction or vis-
ual impairment. It predominantly affects adults in their
third and fourth decades [1]. Even if high-quality epide-
miologic studies are lacking, the available data suggest
an incidence of 0.67 cases per 100,000 children per year.
The prevalence of childhood CVT varies according to
age; neonates are the most commonly affected [2-4].
The signs and symptoms of CVT are frequently non-
specific, often resulting in delayed or missed diagnosis
[5]. In fact, CVT may present with a variety of signs and* Correspondence: elena.bozzola@opbg.net
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unless otherwise stated.symptoms, including irritability, headache, seizure, en-
cephalopathy, papilledema, cranial nerve palsies, motor
weakness and coma [6]. Studies suggest that prompt
diagnosis and anticoagulant therapy may improve out-
come in the majority of patients [2,4,7]. The causes of
CVT may be categorized into three main groups accord-
ing to Virchow’s classification. The first group includes
all hypercoagulable states. The second group consists of
conditions causing blood flow disturbances. Finally, the
third group comprises all causes of inflammation or
infection [8]. Among these, prothrombotic conditions,
either genetic or acquired, malignancy, and head injury
are the most frequent causes. As regards infectious
causes of CVT, these are responsible for only 6 to 12
percent of cases [9]. Previous reports have cited sinusitis,
otitis, and mastoiditis among the principal predisposing
factors. Although the frequency of septic thrombosis isl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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have demonstrated that CVT may be a complication of
meningitis and sepsis in about 7% and 16% of cases,
respectively [2,7,10].
We describe the clinical case of a child with multiple
sinovenous thromboses occurring after the diagnosis of
meningococcal meningitis.
Case presentation
A previously healthy 8 month-old boy presented at the
Emergency Department with high-grade fever, vomiting,
and macular erythema of both upper limbs. No signs
or symptoms of ear and upper respiratory infection
were reported. Physical examination revealed a febrile,
obtunded, and hypotonic child. Otoscopic findings as
well as throat examination were normal. Neck stiffness
was noted. No neurological deficit or papilledema was
present. Laboratory tests showed leukocytosis (27000/μL;
normal value > 6000 and <17000/μL) and an increased
C-reactive protein (19,19 mg/dl; normal value below
0,5 mg/dl). An urgent non-contrast computed tomog-
raphy (CT) of the head and neck was performed, with
normal results. Bacterial meningitis was suspected and a
lumbar puncture confirmed the diagnosis. The cerebro-
spinal fluid (CSF) was opalescent with 33900 white blood
cells, increased total protein (304,2 mg/dl) and normal glu-
cose levels (37 mg/dl). Serum glucose level was also normal
(106 mg/dl).
The child received intravenous dexamethasone and
ceftriaxone as empiric treatment. Neisseria Meningitis C
was confirmed in both blood and CSF cultures. Two
days later, the child’s condition improved, with fever
resolution. Suddenly, seven days after hospital admis-
sion, the child manifested irritability and lethargy. More-
over, a bulging fontanel was noted at the physical
examination. An urgent contrast-enhanced CT of the
head and neck was immediately performed and revealed
thrombosis of the superior sagittal, transverse and rectus
sinuses (Figure 1). Heparin treatment was started in
order to recanalize the occluded sinuses and to prevent
the propagation of thrombi. A thrombophilic evaluation
was performed which revealed hyperhomocysteinemia
and methylenetetrahydrofolate reductase (MTHFR) vari-
ants (C677T and A1298C). One week later, a new CT
revealed a recanalization of the previously involved si-
nuses, without parenchymal damage. Consequently, the
patient was discharged under treatment with subcutane-
ous low molecular weight heparin (LMWH). At follow
up five months later, the child was in good clinical con-
dition with normal magnetic resonance imaging (MRI)
results (Figure 2). The anticoagulant therapy was discon-
tinued, but the family was advised to administer antico-
agulants in case of situations that could predispose to
thrombosis.Conclusions
According to the literature, CVT may be caused by hy-
percoagulable states, by conditions causing blood flow
disturbances, or by inflammation/infection [5]. In our
case report, we observed more than one risk factor that
predisposed to CVT. We speculate that the genetic pro-
thrombotic condition predisposed to CVT, which was
triggered by a central nervous system infection. In fact,
the CT scan was normal at both meningitis onset and
post-discharge follow-up. For this reason, thrombophilic
evaluation should be encouraged in all children with
CVT, independent of other established risk factors such
as meningitis, in order to identify children with in-
creased risk factors for thrombophilia. Thrombophilia
may be defined as a high risk for thrombosis, which can
be either inherited or acquired. The percentage of patients
with CVT who have an identified risk factor for thrombo-
philia varies significantly from study to study, from 33% to
99% [11]. Moreover, there is no consensus as to which
baseline studies should be included in a standard hyperco-
agulability evaluation [12]. In one report, anticardiolipin
antibody was the most common prothrombotic risk factor,
while in another the homozygous MTHFR mutation was
the most common [2,8]. A German study reported cases
in which either elevated lipoprotein A or protein C defi-
ciency was associated with CVT; in an American study,
protein C and antithrombin III deficiencies were common
[7,13]. Other potential procoagulant markers recently con-
sidered in CVT include anemia, hyperhomocysteinemia,
and factor VIII levels.
In the event of a prothrombotic diagnosis, the patient’s
family should be advised to administer drugs (antiplate-
let or anticoagulant agents) in situations that could lead
to thrombosis. In fact, patients recovering from CVT are
at risk of recurrence or other thrombotic event [8]. It
should be explained to patients that testing of their first
degree relatives for heritable thrombophilia will allow the
detection of affected but asymptomatic family members.
Because of its nonspecific presentation, diagnosis of
CVT may be delayed and even missed. Clinicians must
maintain a high index of suspicion when treating any
child with an acute central nervous system infection and
presenting neurological signs and symptoms despite ad-
ministration of appropriate therapy.
Imaging should be considered to rule out intracranial
complications. The currently available diagnostic tools
include head CT, MRI and MR venogram [4,6]. Of these,
head CT is the most commonly performed examination
when sinus thrombosis is suspected [2]. Diagnostic sen-
sitivity is increased with the addition of a postcontrast CT.
The empty delta sign, a classic signature of CVT, is present
on post-contrast CT in 10% to 30% of cases. On head CT
with contrast, the empty delta sign may be seen as a tri-
angular pattern of contrast enhancement surrounding a





Figure 1 Head computed tomography images without (a,b) and with (c,d) contrast; axial (a,c) and reformatted sagittal (b,d) images.
Note the empty delta sign (c, arrow).
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posterior part of the superior sagittal sinus [2,4]. A dense
cord sign (hyperdense fresh blood clot) is seen on noncon-
trast head CT in 1% to 5% of cases [4]. A previous normal
result, even if performed just a few days prior, should not
influence the clinician’s decision to repeat the exam. In
case of CVT, follow-up imaging of the venous sinuses is
generally performed in order to check thrombosis evolu-
tion. The mainstay of CVT treatment is anticoagulation
and supportive care. The purpose of anticoagulant therapy
is to limit the propagation of an existing clot and to
prevent the formation of further thrombi [2,4]. Previous
studies have reported encouraging data on the safety
of anticoagulation therapy in children with CVT and
on improved cognitive outcome [2,7]. Although definitive
evidence of effectiveness is lacking, there is a general
consensus that anticoagulation with unfractionated intra-
venous heparin or subcutaneous LMWH is appropriate
treatment for acute CVT [14]. The treatment most used
for infants and children is LMWH for 7–10 days (120-
180 UI/kg twice a day in children up to 1 year of age, and
100 UI/Kg twice a day in older patients) followed by oral
anticoagulants or antiplatelets generally for 3–6 months
[7]. Therapy is generally discontinued 6 months after the
acute phase but may be prolonged after hematological
evaluation depending on the patient’s age and clinical
condition. Instructions to the family at patient’s discharge
include the necessity to continue anticoagulation after
the acute phase in order to prevent CVT recurrence.
Finally, CVT in children sometimes has a poor prog-
nosis despite prompt diagnosis and therapy. Commonly
identified morbidities include motor dysfunction, neuro-
psychiatric disorders, visual impairment, pseudotumor
cerebri, seizures, and headaches [4]. In our case, even
though CVT involved multiple sinuses and the child was
affected by both meningitis and sepsis, the prognosis
was good, with no sequelae at five months follow-up. The
early diagnosis led to prompt therapy and consequently
enabled a good neurodevelopmental outcome.
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